Comparing long-term value creation after biotech and non-biotech IPOs, 1997–2016

We compared the financial performance of 319 BIOTECH companies focused on developing therapeutics with IPOs from 1997–2016, to that of paired, non-biotech CONTROL companies with concurrent IPO dates. BIOTECH companies had a distinctly different financial structure with high R&D expense, little r...

Descripción completa

Detalles Bibliográficos
Autores principales: Cleary, Ekaterina Galkina, McNamee, Laura M., de Boer, Skyler, Holden, Jeremy, Fitzgerald, Liam, Ledley, Fred D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787373/
https://www.ncbi.nlm.nih.gov/pubmed/33406113
http://dx.doi.org/10.1371/journal.pone.0243813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787373/
https://www.ncbi.nlm.nih.gov/pubmed/33406113
http://dx.doi.org/10.1371/journal.pone.0243813

Ejemplares similares